Sabine Möhner

Publications

Möhner Sabine, Becker Kerstin, Lange Jens, von Stockum Sophia, Serrani Marco, Heinemann Klaas, Long-term treatment of endometriosis with dienogest: Real-world results from the VIPOS study Journal of Endometriosis and Pelvic Pain Disorders. 2021; 10.1177/2284026521993688.

Heinemann Klaas, Imthurn Bruno, Marions Lena, Gerlinger Christoph, Becker Kerstin, Möhner Sabine, Faustmann Thomas, Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study Advances in Therapy. 2020; 2528-2537. 10.1007/s12325-020-01331-z.

Möhner Sabine, Becker Kerstin, Lange Jens, von Stockum Sophia, Heinemann Klaas, Risk of depression and anemia in users of hormonal endometriosis treatments: Results from the VIPOS study European Journal of Obstetrics &Gynecology and Reproductive Biology. 2020; 212 - 217. 10.1016/j.ejogrb.2020.05.049.

Dinger Jürgen, Möhner Sabine, Heinemann Klaas, Combined oral contraceptives containing dienogest and estradiol valerate may carry a lower risk of venous and arterial thromboembolism compared to conventional preparations: Results from the extended INAS-SCORE study. Frontiers in Women's Health. 2020; Vol. 5: 1-8. 10.15761/FWH.1000178.
Download PDF: Jürgen-et-al.-2020_Results-from-the-extended-INAS-SCORE-study.pdf

Barnett Clare, Möhner Sabine, Do Minh Thai, Heinemann Klaas, Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study The European Journal of Contraception and Reproductive Health Care. 2018; page 1-5.

Heinemann Klaas, Barnett Clare, Reed Suzanne, Möhner Sabine, Do Minh Thai, IUD use among parous women and risk of uterine perforation: a secondary analysis Contraception. 2017; Volume 95, Issue 6, Pages 605–607.

Hagemann Christine, Heinemann Klaas, Möhner Sabine, Safety and efficacy of intrauterine devices: Baseline characteristics of 32,022 study participants from the EURAS-LCS12 study Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue Supplement S2 Pages 1–674.

Bauerfeind Anja, Möhner Sabine, Do Minh Thai, Heinemann Klaas, The Influence of Women’s Educational Level on Unintended Pregnancy Rates amongst Users of Combined Oral Contraceptives Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue Supplement S2 Pages 1–674.

Heinemann Klaas, Möhner Sabine, Reed Suzanne, Do Minh Thai, Unwanted pregnancies in women using Intrauterine Devices: final results from the EURAS-IUD 5-years study Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.

Heinemann Klaas, Möhner Sabine, Do Minh Thai, Reed Suzanne, Intrauterine Devices and the Risk of Uterine Perforations: Final Results from the EURAS-IUD 5-years study Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.

Heinemann Klaas, Reed Suzanne, Möhner Sabine, Do Minh Thai, Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Contraception. 2015; Apr;91(4):280-3. 10.1016/j.contraception.2015.01.011.

Bardenheuer Kristina, Dinger Jürgen, Hagemann Christine, Möhner Sabine, Franke Christian, Unintended pregnancies in users of different combined oral contraceptives - final results from the INAS-SCORE study. Pharmacoepidemiology and Drug Safety. 2015; 24 (S1): 1–587. 10.1002/pds.3838.

Heinemann Klaas, Reed Suzanne, Möhner Sabine, Do Minh Thai, Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Contraception. 2015; 10.1016/j.contraception.2015.01.007.

Heinemann Klaas, Reed Suzanne, Möhner Sabine, Ectopic pregnancies under IUD use: interim results from the EURAS-IUD study Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.

Heinemann Klaas, Reed Suzanne, Möhner Sabine, Breastfeeding as as risk factor for uterine preforation during IUD insertion: interim results from the ERUAS-IUD study Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.

Möhner Sabine, Dinger Jürgen, Heinemann Klaas, Transatlantic active surveillance of cardiovascular safety (TASC) of an Etonogestrel/Ethinylestradiol-containing vaginal ring. Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.

Dinger Jürgen, Möhner Sabine, Heinemann Klaas, Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring. Obstetrics & Gynecology. 2013; 122(4): 800 - 808. 10.1097/AOG.0b013e3182a5ec6b.
Download PDF: Cardiovascular_Risk_Associated_With_the_Use_of_an.11.pdf

Heinemann Klaas, Assmann Anita, Möhner Sabine, Long term active surveillance study for oral contraceptives (LASS): final results on cardiovascular safety. Pharmacoepidemiology and Drug Safety. 2012; Aug; 21(S3) 360. DOI 10.1002.

Möhner Sabine, Dinger Jürgen, Franke Christian, Use of hormonal contraceptives in europe and in the USA: comparative data from the TASC study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 182.

Dinger Jürgen, Assmann Anita, Möhner Sabine, Oral contraceptives and the risk of VTE: reanalysis of the EURAS/LASS study. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 74.

Dinger Jürgen, Bardenheuer Kristina, Möhner Sabine, The risk of vaenous thromboembolism in users of a drospirenone-containing oral contraceptive with a 24-day regimen - results from the INAS-OC study. Fertility and Sterility. 2010; 94 suppl 1:S3.

Bardenheuer Kristina, Dinger Jürgen, Möhner Sabine, Assmann Anita, Leddin Janko, Unterschiede in der europäischen und US-amerikanischen Studienpopulation am Beispiel INAS-OC. Gesundheitswesen. 2010; 72:624.

Bardenheuer Kristina, Dinger Jürgen, Möhner Sabine, Franke Christian, Sicherheit und effektivität von oralen kontrazeptiva bei jugendlichen. Gesundheitswesen. 2010; 72:624.

Dinger Jürgen, Assmann Anita, Möhner Sabine, Do Minh Thai, Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. J Fam Plann Reprod Health Care. 2010; 36(3):123-129.

Dinger Jürgen, Assmann Anita, Möhner Sabine, Long-term active surveillance study for oral contraceptives (LASS): Impact of oral contraceptive use on the start of antihypertensive treatment. Pharmacoepidemiology and Drug Safety. 2010; 19:S232.

Dinger Jürgen, Do Minh Thai, Möhner Sabine, The risk of venous thromboembolism in OC users: time patterns after initiation of treatment. Pharmacoepidemiology and Drug Safety. 2010; 19:S214-215.

Dinger Jürgen, Barnett Clare, Möhner Sabine, Assmann Anita, Unintended pregnancies in women using intrauterine devices: Results from the EURAS-IUD study. Pharmacoepidemiology and Drug Safety. 2010; 19:S242.

Dinger Jürgen, Bardenheuer Kristina, Möhner Sabine, Breast cancer risk associated with the use of levonorgestrel-containing intrauterine devices compared to copper intrauterine devices. Eur J Contracept Reprod Health Care. 2010; S1:46-47.

Dinger Jürgen, Assmann Anita, Möhner Sabine, Bardenheuer Kristina, Safety long-term active surveillance study for oral contraceptives (LASS): Results on venous and arterial thromboembolism. Eur J Conctracept Reprod Health Care. 2010; S1:128.

Dinger Jürgen, Möhner Sabine, Do Minh Thai, Early use effects on the risk of venous thromboembolism after initiation of oral contraceptive use. Eur J Contracept Reprod Health Care. 2010; 15;S1:43.

Dinger Jürgen, Cronin Maureen, Möhner Sabine, Schellschmidt Ilka, Do Minh Thai, Westhoff C, Oral contraceptive effectiveness according to body mass index, weight, age, and other factors. Am J Obstet Gynecol. 2009; Sep;201(3):263.e1-9. doi: 10.1016/j.ajog.2009.03.017.

Dinger Jürgen, Assmann Anita, Möhner Sabine, The safety of HRT under real life conditions: interim results from the EURAS HRT study. Gynecol Endocrinol. 2008; 24: S51.

Raff T, Dinger Jürgen, Heinemann Lothar A , Möhner Sabine, Do Minh Thai, The risk of uterine and ovarian cancer for different formulations of hormone therapy (HT). The Open Epidemiology Journal. 2008; 1:17-25.

van der Woude Fokke J , Heinemann Lothar A , Graf H, Lewis Michael, Möhner Sabine, Assmann Anita, Kuehl-Habich D, Analgesics use and ESRD in younger age: a case-control study BMC Nephrology. 2007; 8:15.

Dinger Jürgen, Heinemann Lothar A , Möhner Sabine, Do Minh Thai, Assmann Anita, No increased risk of colon cancer associated with various HRT formulations: a case-control study BMC Cancer. 2007; 7:76. doi:10.1186/1471-2407-7-76.

Dinger Jürgen, Heinemann Lothar A , Möhner Sabine, Do Minh Thai, Assmann Anita, Colon cancer risk and different HRT formulations: a case-control study. BMC Cancer. 2007; 8;7:76.

Dinger Jürgen, Heinemann Lothar A , Möhner Sabine, Do Minh Thai, Assmann Anita, Breast cancer risk associated with different HRT formulations: a register-based case-control study. BMC Women's Health. 2006; 6:13.

Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Möhner Sabine, Assmann Anita, Thiel C, The risk of gynaecological cancers associated with different HRT formulations. A nested case-control study in the German Cohort Study on Women’s Health. Geburth Frauenheilk. 2006; 66:145-155.

Schellschmidt I, Do Minh Thai, Möhner Sabine, Dinger Jürgen, Factors influencing return to fertility after use of oral contraceptives. Pharmacoepidemiology and Drug Safety. 2006; 15: S25.

Heinemann Klaas, Thiel C, Möhner Sabine, Lewis Michael, Raff T, Heinemann Lothar A , Benign gynecological tumors: estimated incidence. Results of the German Cohort study on Women’s Health Eur J Obst Gyn Reprod Biol. 2003; 107: 78-80.

Heinemann Lothar A , Lewis Michael, Kuehl-Habich D, Braendle W, Möhner Sabine, Cancer of the uterus and ovary and lifetime history of oral contraceptive use. A German case-control study. Geburth.Frauenheilk. 2003; 63:1018-26.

Heinemann Lothar A , Lewis Michael, Kuehl-Habich D, Braendle W, Garbe E, Möhner Sabine, Lifetime history of oral contraceptive use and development of the uterus and ovary. Geburth Frauenheilk. 2002; 62:566-573. DOI: 10.1055/s-2002-32421.

Heinemann Lothar A , Lewis Michael, Kuehl-Habich D, Braendle W, Möhner Sabine, The risk of breast tumors and lifetime history of oral contraceptive use Geburtshilfe und Frauenheilkund. 2002; 62(8):750-757.

Heinemann Klaas, Möhner Sabine, Assmann Anita, Lewis Michael, Garbe E, Heinemann Lothar A , Teichmann A T, Trend der HRT Nutzung in Deutschland 1980-1999. Ergebnisse der Deutschen Kohortenstudie zur Frauengesundheit. 2002; 43:508-511.

Heinemann Klaas, Möhner Sabine, Lewis Michael, Assmann Anita, Garbe E, Heinemann Lothar A , Trend der OC-Nutzung in einer Deutschen Frauen-Kohorte 1980-1999 Zentralbl Gynakol. 2002; 124(2): 128-131. DOI: 10.1055/s-2002-24241.

Heinemann Klaas, Heinemann Lothar A , Assmann Anita, Möhner Sabine, Schneider HPG, Reliabilität der Menopause-Rating-Skala (MRS). Untersuchung für die Deutsche Bevölkerung Zentralbl Gynakol. 2002; 124(3): 161-163. DOI: 10.1055/s-2002-32268.

Heinemann Lothar A , Thiel C, Assmann Anita, Möhner Sabine, Gründe und Häufigkeit von Wechsel/Stopp der Einnahme oraler Kontrazeptiva. Ergebnisse der Deutschen Kohortenstudie zur Frauengesundheit. Zentralbl Gynakol. 2001; 123(10): 568-577. DOI: 10.1055/s-2001-19090.

Heinemann Lothar A , Möhner Sabine, Assmann Anita, Heinemann Klaas, Use of oral contraceptives containing dienogest and risk of venous thromboembolism; an extended summary report. Life and Medical Science Online. 2001; 2.